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Background: Dilated cardiomyopathy (DCM) commonly causes heart failure and shows extensive genetic heterogeneity that may be amenable to 
newly developed Next-Generation DNA sequencing of the exome. In this study we report the first successful use of exome sequencing to identify a 
pathogenic variant in the TNNT2 gene using segregation analysis in a large DCM family.
methods and results: Exome sequencing was performed on three distant relatives from a large family with a clear DCM phenotype and 
missense, nonsense, and splice variants were analyzed for segregation among the three affected family members and confirmed in other relatives 
by direct sequencing. A c.517T C>T, Arg173Trp TNNT2 variant segregated with all affected family members and was also detected in one additional 
family in the Registry. The inclusion of segregation analysis using distant family members markedly improved the bioinformatics filtering process by 
removing from consideration suspicious variants that were not shared by all affected subjects. Haplotype analysis confirmed that the variant found in 
both families was located on two distinct haplotypes, supporting the notion of independent mutational events.
conclusion: An exome sequencing strategy that includes segregation analysis using distant affected relatives within a family represents a viable 
diagnostic strategy in a genetically heterogeneous disease like DCM.
